Conavi Medical Corp.
CNVIF
$0.26
$0.00461.80%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.79M | 4.19M | 1.55M | 2.66M | 2.45M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.79M | 4.19M | 1.55M | 2.66M | 2.45M |
| Cost of Revenue | 1.12M | 1.64M | 1.56M | 1.67M | 1.42M |
| Gross Profit | 2.67M | 2.55M | -6.20K | 994.00K | 1.03M |
| SG&A Expenses | 5.20M | 5.27M | 5.22M | 5.16M | 4.64M |
| Depreciation & Amortization | 624.70K | 670.00K | 716.50K | 774.60K | 843.20K |
| Other Operating Expenses | 292.60K | 292.60K | 279.50K | 239.00K | 239.00K |
| Total Operating Expenses | 20.60M | 21.68M | 21.30M | 22.00M | 19.89M |
| Operating Income | -16.81M | -17.50M | -19.75M | -19.34M | -17.43M |
| Income Before Tax | -27.12M | -30.22M | -31.92M | -25.38M | -20.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.12 | -30.22 | -31.92 | -25.38 | -20.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.12M | -30.22M | -31.92M | -25.38M | -20.40M |
| EBIT | -16.81M | -17.50M | -19.75M | -19.34M | -17.43M |
| EBITDA | -16.40M | -17.03M | -19.23M | -18.83M | -16.85M |
| EPS Basic | -3.59 | -4.40 | -5.18 | -4.12 | -3.31 |
| Normalized Basic EPS | -1.63 | -2.13 | -2.59 | -2.42 | -2.11 |
| EPS Diluted | -3.59 | -4.40 | -5.18 | -4.12 | -3.31 |
| Normalized Diluted EPS | -1.63 | -2.13 | -2.59 | -2.42 | -2.11 |
| Average Basic Shares Outstanding | 98.73M | 60.64M | 24.64M | 24.63M | 24.63M |
| Average Diluted Shares Outstanding | 98.73M | 60.64M | 24.64M | 24.63M | 24.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |